Keith Laderoute
5Patents
3h-index
15Co-inventors
54Inventor score
Filing activity: Jun 23, 1997 → Dec 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6433012B1 | Method for inhibiting inflammatory disease | Human Necessities | 35 | Expired |
| US6169104A | Di-aryl ethers and their derivatives as anti-cancer agents | Emerging Cross-Sectional Technologies | 22 | Expired |
| US6150407A | Methods for inhibiting angiogenesis | Human Necessities | 16 | Expired |
| US6218179A | Tissue specific hypoxia regulated constructs | Chemistry; Metallurgy | 2 | Expired |
| US12163948B2 | Apparatuses and methods involving protein exploration through proteolysis and nanopore translocation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.